PROCEPT BioRobotics Analyst Price Targets

Wall Street analyst price targets and consensus rating for PROCEPT BioRobotics (PRCT).

Price Target Range — 13 Quarters

Analyst Consensus — 14 Analysts

6Buy

7Hold

1Sell

Consensus RatingOverweight# Analysts14Avg. Consensus PT$34Upside to Avg. PT+71.2%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 7, 2026	Barclays	Christopher Pasquale	Initiate	Overweight	$30
Aug 5, 2026	TD Cowen	Joshua Jennings	PT Cut	Buy	$34→$28
Aug 5, 2026	Piper Sandler	Matt O'Brien	PT Cut	Overweight	$35→$25
Aug 5, 2026	Evercore ISI Group	Vijay Kumar	PT Cut	Outperform	$30→$23
Aug 5, 2026	William Blair	Brandon Vazquez	Downgrade	Outperform→Market Perform	—
Jul 28, 2026	UBS	Danielle Antalffy	Assumes	Buy→Neutral	$20
Jul 6, 2026	Truist Securities	Richard Newitter	Downgrade	Buy→Hold	$30→$25
Jun 24, 2026	Evercore ISI Group	Vijay Kumar	Initiate	Outperform	$30
Jun 11, 2026	Leerink Partners	Mike Kratky	Downgrade	Outperform→Market Perform	$31→$29
Apr 30, 2026	Piper Sandler	Matt O'Brien	PT Raise	Overweight	$28→$35
Mar 6, 2026	Baird	David Rescott	Initiate	Neutral	$30
Mar 2, 2026	Truist Securities	Richard Newitter	PT Cut	Buy	$47→$30
Feb 26, 2026	Leerink Partners	Mike Kratky	PT Cut	Outperform	$55→$30
Feb 26, 2026	TD Cowen	Joshua Jennings	PT Cut	Buy	$50→$34
Feb 26, 2026	Oppenheimer	Suraj Kalia	Downgrade	Outperform→Perform	—
Feb 26, 2026	Piper Sandler	Matt O'Brien	PT Cut	Overweight	$50→$28
Feb 26, 2026	Wells Fargo	Nathan Treybeck	PT Cut	Overweight	$51→$34
Feb 26, 2026	B of A Securities	Craig Bijou	Downgrade	Neutral→Underperform	$38→$20
Dec 18, 2025	Truist Securities	Richard Newitter	PT Cut	Buy	$50→$47
Dec 12, 2025	UBS	Danielle Antalffy	Initiate	Buy	$62

Analyst Ratings News

PRO
Barclays Initiates Coverage On PROCEPT BioRobotics with Overweight Rating, Announces Price Target of $30

Barclays analyst Christopher Pasquale initiates coverage on PROCEPT BioRobotics (NASDAQ:PRCT) with a Overweight rating and announces Price Target of $30.

Benzinga Newsdesk

PRO
TD Cowen Maintains Buy on PROCEPT BioRobotics, Lowers Price Target to $28

TD Cowen analyst Joshua Jennings maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Buy and lowers the price target from $34 to $28.

Benzinga Newsdesk

PRO
Piper Sandler Maintains Overweight on PROCEPT BioRobotics, Lowers Price Target to $25

Piper Sandler analyst Matt O'Brien maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Overweight and lowers the price target from $35 to $25.

Benzinga Newsdesk

PRO
Evercore ISI Group Maintains Outperform on PROCEPT BioRobotics, Lowers Price Target to $23

Evercore ISI Group analyst Vijay Kumar maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Outperform and lowers the price target from $30 to $23.

Benzinga Newsdesk

PRO
William Blair Downgrades PROCEPT BioRobotics to Market Perform

William Blair analyst Brandon Vazquez downgrades PROCEPT BioRobotics (NASDAQ:PRCT) from Outperform to Market Perform.

Benzinga Newsdesk

PRO
Truist Securities Downgrades PROCEPT BioRobotics to Hold, Lowers Price Target to $25

Truist Securities analyst Richard Newitter downgrades PROCEPT BioRobotics (NASDAQ:PRCT) from Buy to Hold and lowers the price target from $30 to $25.

Benzinga Newsdesk

PROCEPT BioRobotics Corp

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

PROCEPT BioRobotics Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Barclays Initiates Coverage On PROCEPT BioRobotics with Overweight Rating, Announces Price Target of $30

PRO
TD Cowen Maintains Buy on PROCEPT BioRobotics, Lowers Price Target to $28

PRO
Piper Sandler Maintains Overweight on PROCEPT BioRobotics, Lowers Price Target to $25

PRO
Evercore ISI Group Maintains Outperform on PROCEPT BioRobotics, Lowers Price Target to $23

PRO
William Blair Downgrades PROCEPT BioRobotics to Market Perform

PRO
Truist Securities Downgrades PROCEPT BioRobotics to Hold, Lowers Price Target to $25

People Also Watch

People Also Watch

PROCEPT BioRobotics Corp

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

PROCEPT BioRobotics Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROBarclays Initiates Coverage On PROCEPT BioRobotics with Overweight Rating, Announces Price Target of $30

PROTD Cowen Maintains Buy on PROCEPT BioRobotics, Lowers Price Target to $28

PROPiper Sandler Maintains Overweight on PROCEPT BioRobotics, Lowers Price Target to $25

PROEvercore ISI Group Maintains Outperform on PROCEPT BioRobotics, Lowers Price Target to $23

PROWilliam Blair Downgrades PROCEPT BioRobotics to Market Perform

PROTruist Securities Downgrades PROCEPT BioRobotics to Hold, Lowers Price Target to $25

People Also Watch

People Also Watch

PRO
Barclays Initiates Coverage On PROCEPT BioRobotics with Overweight Rating, Announces Price Target of $30

PRO
TD Cowen Maintains Buy on PROCEPT BioRobotics, Lowers Price Target to $28

PRO
Piper Sandler Maintains Overweight on PROCEPT BioRobotics, Lowers Price Target to $25

PRO
Evercore ISI Group Maintains Outperform on PROCEPT BioRobotics, Lowers Price Target to $23

PRO
William Blair Downgrades PROCEPT BioRobotics to Market Perform

PRO
Truist Securities Downgrades PROCEPT BioRobotics to Hold, Lowers Price Target to $25